Compile Data Set for Download or QSAR

Found 2 hits Enz. Inhib. hit(s) with Target = 'Tyrosine-protein kinase BTK' and Ligand = 'BDBM291403'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM291403 (1-(6-((6-amino-5-(4-(pyridin-4-yloxy)phenyl)pyrimi...) Show SMILES Nc1ncnc(OC2CC3(C2)CN(C3)C(=O)C=C)c1-c1ccc(Oc2ccncc2)cc1 Show InChI InChI=1S/C24H23N5O3/c1-2-20(30)29-13-24(14-29)11-19(12-24)32-23-21(22(25)27-15-28-23)16-3-5-17(6-4-16)31-18-7-9-26-10-8-18/h2-10,15,19H,1,11-14H2,(H2,25,27,28)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
Merck Patent GmbH US Patent					Assay Description 2.5× stocks of full-length human BTK (08-080) from CarnaBio USA, Inc., Natick, Mass., 1.6×ATP and appropriate kinKDR peptide substrate (FITC-AHA-EEPL...				US Patent US10413562 (2019) BindingDB Entry DOI: 10.7270/Q27M0B95
					More data for this Ligand-Target Pair
Tyrosine-protein kinase BTK (Homo sapiens (Human))	BDBM291403 (1-(6-((6-amino-5-(4-(pyridin-4-yloxy)phenyl)pyrimi...) Show SMILES Nc1ncnc(OC2CC3(C2)CN(C3)C(=O)C=C)c1-c1ccc(Oc2ccncc2)cc1 Show InChI InChI=1S/C24H23N5O3/c1-2-20(30)29-13-24(14-29)11-19(12-24)32-23-21(22(25)27-15-28-23)16-3-5-17(6-4-16)31-18-7-9-26-10-8-18/h2-10,15,19H,1,11-14H2,(H2,25,27,28)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	7.5	27
Merck Patent GmbH US Patent					Assay Description The following describes a microfluidic, off-chip mobility shift kinase assay used to measure inherent potency of compounds against BTK enzyme. Compou...				US Patent US9580449 (2017) BindingDB Entry DOI: 10.7270/Q28K7C4Z
					More data for this Ligand-Target Pair